Author

M. To

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

D. K. Nomura· 2 shared J. A. Olzmann· 2 shared T. J. Maimone· 2 shared X. Hu· 2 shared A. Proudfoot· 1 shared C. A. Berdan· 1 shared C. C. Ward· 1 shared C. R. Altobelli· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. K. Nomura

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Harnessing the Anti-Cancer Natural Product Nimbolide for Targeted Protein Degradation

J. N. Spradlin, X. Hu, C. C. Ward, S. M. Brittain, M. D. Jones, L. Ou, M. To, A. Proudfoot, E. Ornleas, M. Woldegiorgis, J. A. Olzmann, D. E. Bussiere, J. R. Thomas, J. A. Tallarico, J. M. McKenna, , D. K. Nomura

This study identifies nimbolide's mechanism of action by showing it targets RNF114, leading to stabilization of p21 and inhibition of breast cancer cell proliferation.

bioRxiv · Apr 9, 2019Cancer Biology

Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells

C. A. Berdan, R. Ho, H. S. Lehtola, M. To, X. Hu, T. R. Huffman, Y. Petri, C. R. Altobelli, S. G. Demeulenaere, J. A. Olzmann, T. J. Maimone, D. K. Nomura

This study identifies parthenolide's covalent targeting of FAK1 in breast cancer cells, showing inhibition of FAK1-dependent pathways and cancer cell proliferation.

bioRxiv · Feb 15, 2019Cancer Biology